Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on (18)F-FDG PET/CT

In this report, we present (18)F-FDG PET/CT findings of reactive left axillary and supraclavicular hypermetabolic lymphadenopathy, as well as ipsilateral deltoid muscle injection site radiotracer uptake, related to recent coronavirus disease 2019 (COVID-19) vaccination in a patient with osteosarcoma...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Mathew V., Yang, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Nuclear Medicine 2021
Materias:
Teaching Case Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712634/
https://www.ncbi.nlm.nih.gov/pubmed/33820864
http://dx.doi.org/10.2967/jnmt.121.262008
Descripción
Sumario:In this report, we present (18)F-FDG PET/CT findings of reactive left axillary and supraclavicular hypermetabolic lymphadenopathy, as well as ipsilateral deltoid muscle injection site radiotracer uptake, related to recent coronavirus disease 2019 (COVID-19) vaccination in a patient with osteosarcoma. With the growing number of patients receiving COVID-19 vaccine, recognition of benign characteristic (18)F-FDG PET/CT image findings will ensure staging and restaging accuracy and avoid unnecessary biopsy.

Ejemplares similares